NCT04518852 2024-06-25TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCCSichuan Cancer Hospital and Research InstitutePhase 2 Completed27 enrolled
NCT01556815 2012-04-25Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaShandong Cancer Hospital and InstitutePhase 2 Unknown40 enrolled